Combined Administration of Gallic Acid and Glibenclamide Mitigate Systemic Complication and Histological Changes in the Cornea of Diabetic Rats Induced with Streptozotocin

Overview

Journal Acta Cir Bras

Specialty General Surgery

Date 2024 Feb 7

PMID 38324798

Authors

Jing Zhao

Shaik Althaf Hussain

Narendra Maddu

Affiliations

Soon will be listed here.

Abstract

Purpose: To determine the effect of gallic acid or its combination with glibenclamide on some biochemical markers and histology of the cornea of streptozotocin (STZ) induced diabetic rats.

Methods: Following induction of diabetes, 24 male albino rats were divided into four groups of six rats each. Groups 1 and 2 (control and diabetic) received rat pellets and distilled water; group 3 (gallic acid) received rat pellets and gallic acid (10 mg/kg, orally) dissolved in the distilled water; and group 4 (gallic acid + glibenclamide) received rat pellets, gallic acid (10 mg/kg, orally), and glibenclamide (5 mg/kg, orally) dissolved in the distilled water. The treatments were administered for three months after which the rats were sacrificed after an overnight fast. Blood and sera were collected for the determination of biochemical parameters, while their eyes were excised for histology.

Results: STZ administration to the rats induced insulin resistance, hyperglycemia, microprotenuria, loss of weight, oxidative stress, inflammation, and alteration of their cornea histology, which was abolished following supplementation with gallic acid or its combination with glibenclamide.

Conclusions: The study showed the potentials of gallic acid and glibenclamide in mitigating systemic complication and histological changes in the cornea of diabetic rats induced with STZ.

References

Nahar N, Mohamed S, Mustapha N, Lau S, Mohd Ishak N, Umran N . Metformin attenuated histopathological ocular deteriorations in a streptozotocin-induced hyperglycemic rat model. Naunyn Schmiedebergs Arch Pharmacol. 2020; 394(3):457-467. DOI: 10.1007/s00210-020-01989-w. View

Nathan D, Buse J, Davidson M, Ferrannini E, Holman R, Sherwin R . Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008; 32(1):193-203. PMC: 2606813. DOI: 10.2337/dc08-9025. View

Vieira-Potter V, Karamichos D, Lee D . Ocular Complications of Diabetes and Therapeutic Approaches. Biomed Res Int. 2016; 2016:3801570. PMC: 4826913. DOI: 10.1155/2016/3801570. View

Winterbourn C, Hawkins R, Brian M, Carrell R . The estimation of red cell superoxide dismutase activity. J Lab Clin Med. 1975; 85(2):337-41. View

Chang J, Gabison E, Kato T, Azar D . Corneal neovascularization. Curr Opin Ophthalmol. 2001; 12(4):242-9. DOI: 10.1097/00055735-200108000-00002. View

Resnikoff S, Pascolini D, Etyaale D, Kocur I, Pararajasegaram R, Pokharel G . Global data on visual impairment in the year 2002. Bull World Health Organ. 2005; 82(11):844-51. PMC: 2623053. DOI: /S0042-96862004001100009. View

Mestry S, Dhodi J, Kumbhar S, Juvekar A . Attenuation of diabetic nephropathy in streptozotocin-induced diabetic rats by Linn. leaves extract. J Tradit Complement Med. 2017; 7(3):273-280. PMC: 5506633. DOI: 10.1016/j.jtcme.2016.06.008. View

Liu H, Chang C, Yang T, Chiang M . Long-term feeding of red algae (Gelidium amansii) ameliorates glucose and lipid metabolism in a high fructose diet-impaired glucose tolerance rat model. J Food Drug Anal. 2017; 25(3):543-549. PMC: 9328806. DOI: 10.1016/j.jfda.2016.06.005. View

Sunmonu T, Afolayan A . Evaluation of Antidiabetic Activity and Associated Toxicity of Artemisia afra Aqueous Extract in Wistar Rats. Evid Based Complement Alternat Med. 2013; 2013:929074. PMC: 3687504. DOI: 10.1155/2013/929074. View

10.

Calderon Guzman D, Juarez Olguin H, Garcia E, Valenzuela Peraza A, de la Cruz D, Soto M . Mechanisms involved in the development of diabetic retinopathy induced by oxidative stress. Redox Rep. 2016; 22(1):10-16. PMC: 6837689. DOI: 10.1080/13510002.2016.1205303. View

11.

Singh A, Singh R, Chakraborty P . Diabetes Monotherapies versus Metformin-Based Combination Therapy for the Treatment of Type 2 Diabetes. Int J Gen Med. 2021; 14:3833-3848. PMC: 8318007. DOI: 10.2147/IJGM.S295459. View

12.

Gandhi G, Jothi G, Antony P, Balakrishna K, Paulraj M, Ignacimuthu S . Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling.... Eur J Pharmacol. 2014; 745:201-16. DOI: 10.1016/j.ejphar.2014.10.044. View

13.

Canovai A, Amato R, Melecchi A, Dal Monte M, Rusciano D, Bagnoli P . Preventive Efficacy of an Antioxidant Compound on Blood Retinal Barrier Breakdown and Visual Dysfunction in Streptozotocin-Induced Diabetic Rats. Front Pharmacol. 2022; 12:811818. PMC: 8762314. DOI: 10.3389/fphar.2021.811818. View

14.

Patel S, Goyal R . Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats. Pharmacognosy Res. 2012; 3(4):239-45. PMC: 3249782. DOI: 10.4103/0974-8490.89743. View

15.

Kim J, Kim C, Sohn E, Jeong I, Kim H, Kim J . Involvement of advanced glycation end products, oxidative stress and nuclear factor-kappaB in the development of diabetic keratopathy. Graefes Arch Clin Exp Ophthalmol. 2010; 249(4):529-36. DOI: 10.1007/s00417-010-1573-9. View

16.

Yu Y, Zhou X, Ye L, Yuan Q, Freeberg S, Shi C . Rhamnazin attenuates inflammation and inhibits alkali burn-induced corneal neovascularization in rats. RSC Adv. 2022; 8(47):26696-26706. PMC: 9083096. DOI: 10.1039/c8ra03159b. View

17.

Markoulli M, Flanagan J, Tummanapalli S, Wu J, Willcox M . The impact of diabetes on corneal nerve morphology and ocular surface integrity. Ocul Surf. 2017; 16(1):45-57. DOI: 10.1016/j.jtos.2017.10.006. View

18.

Zhou J, Kang X, Luo Y, Yuan Y, Wu Y, Wang M . Glibenclamide-Induced Autophagy Inhibits Its Insulin Secretion-Improving Function in Cells. Int J Endocrinol. 2019; 2019:1265175. PMC: 6714319. DOI: 10.1155/2019/1265175. View

19.

Lamos E, Stein S, Davis S . Combination of glibenclamide-metformin HCl for the treatment of type 2 diabetes mellitus. Expert Opin Pharmacother. 2012; 13(17):2545-54. DOI: 10.1517/14656566.2012.738196. View

20.

Abdul-Hamid M, Moustafa N . Amelioration of alloxan-induced diabetic keratopathy by beta-carotene. Exp Toxicol Pathol. 2013; 66(1):49-59. DOI: 10.1016/j.etp.2013.08.003. View